Description
(Specs for PharmaEvo) The gastrointestinal lipases are reversibly inhibited by orlistat. It forms a covalent link with the active serine residue location of pancreatic and gastric lipases to exert its therapeutic activity in the lumen of the stomach and small intestine.




Reviews
There are no reviews yet.